Moderate

Yaws joint pain - Causes, Treatment & When to See a Doctor

Yaws‑Related Joint Pain – Causes, Diagnosis & Treatment

What is Yaws joint pain?

Yaws is a chronic skin‑and‑bone infection caused by the bacterium Treponema pallidum pertenue. While the disease is most famous for its painful, ulcerating skin lesions, many patients eventually develop inflammation of the joints—commonly referred to as “yaws joint pain.” This type of arthralgia typically appears months to years after the initial skin outbreak and can affect multiple joints, especially the knees, ankles, elbows and wrists. The pain is usually dull‑to‑moderate, may be worse after walking or using the joint, and can be accompanied by swelling or a limited range of motion.

Yaws primarily occurs in tropical, low‑resource settings where sanitation and access to health care are limited. The World Health Organization (WHO) estimates that about 15 million people live in areas endemic for yaws, with periodic outbreaks reported in West Africa, Southeast Asia and the Pacific islands.

Because the bacterium is closely related to the one that causes syphilis, the disease follows a similar three‑stage pattern: primary (skin lesion), secondary (systemic spread with skin and bone involvement) and tertiary (late complications, including joint disease). Recognizing joint pain as a possible late manifestation of yaws is essential for timely treatment and for preventing long‑term disability.

Common Causes

Joint pain can arise from many different conditions, not just yaws. Below is a list of 10 common causes of arthralgia, with a brief note on how they differ from yaws‑related pain.

  • Yaws (Treponema pallidum pertenue) – late‑stage bone involvement causing symmetric or asymmetric joint pain, often after a skin episode.
  • Rheumatoid arthritis – autoimmune disease that produces symmetric morning stiffness and rheumatoid nodules.
  • Osteoarthritis – wear‑and‑tear degeneration, usually in older adults, worsens with activity and improves with rest.
  • Post‑infectious reactive arthritis – follows bacterial infections such as Chlamydia, Salmonella, or Shigella; commonly involves the knees, ankles and sacroiliac joints.
  • Lyme disease – caused by Borrelia burgdorferi; joint pain often migrates and may be accompanied by a characteristic bull’s‑eye rash.
  • Gout – uric acid crystal deposition, typically causing sudden, severe pain in the big toe (podagra).
  • Pseudogout (calcium pyrophosphate deposition disease) – similar to gout but affects larger joints like the knee.
  • Septic arthritis – bacterial infection within a joint, producing rapid-onset severe pain, swelling, and fever.
  • Systemic lupus erythematosus (SLE) – autoimmune disease with joint pain plus rash, kidney involvement, and photosensitivity.
  • Trauma or over‑use injuries – sprains, strains or repetitive‑stress injuries that cause localized pain and swelling.

Distinguishing yaws joint pain from these other etiologies often relies on a combination of patient history, travel/residence in endemic areas, and specific laboratory testing.

Associated Symptoms

The presence of other clinical features helps clinicians identify yaws as the underlying cause of joint pain. Common co‑occurring signs include:

  • Primary skin lesion – a painless, pink‑to‑brown papule that later ulcerates, often on the legs or face.
  • Secondary skin eruptions – widespread “raspberry‑like” papules that appear weeks after the primary lesion.
  • Bone tenderness – especially over long bones (tibia, femur) and joints; may be palpable as a firm, achy area.
  • Swelling of joints (synovitis) – mild to moderate effusion, most often in the knees, ankles, elbows, and wrists.
  • Fever or low‑grade chills – particularly during the secondary stage.
  • Fatigue and malaise – non‑specific but common in systemic bacterial infections.
  • Growth disturbances in children – chronic bone involvement can lead to shortening of limbs or deformities.

When to See a Doctor

Because untreated yaws can cause permanent joint damage and deformity, early medical evaluation is critical. Seek professional care if you notice any of the following:

  • Joint pain that persists for more than a week or worsens despite rest.
  • Swelling, redness, or warmth over a joint, especially if accompanied by fever.
  • New or recurrent skin lesions that resemble painless ulcers, particularly after travel to or residence in a tropical region.
  • Difficulty bearing weight on a leg or using an arm due to pain.
  • Signs of systemic illness—persistent fever, unexplained weight loss, or night sweats.
  • Any joint pain in a child who has recently been in a yaws‑endemic community.

Prompt treatment not only relieves symptoms but also prevents the spread of infection to others.

Diagnosis

Diagnosing yaws‑related joint pain involves a stepwise approach that combines clinical assessment with targeted investigations.

1. Detailed History & Physical Exam

  • Ask about recent travel, residence, or contact with people from endemic areas.
  • Document the pattern of skin lesions (location, size, evolution).
  • Examine all joints for swelling, tenderness, range of motion, and deformity.

2. Laboratory Tests

  • Serologic testing – Non‑treponemal tests (RPR, VDRL) are usually positive in active infection; confirm with treponemal tests (TPPA, FTA‑ABS) specific for T. pallidum pertenue.
  • Complete blood count (CBC) – May reveal mild anemia or leukocytosis if secondary infection is present.
  • Erythrocyte sedimentation rate (ESR) / C‑reactive protein (CRP) – Elevated in systemic inflammation.
  • Joint fluid analysis – If effusion is present, aspiration can rule out septic arthritis (negative Gram stain, low white cell count typical for yaws).

3. Imaging Studies

  • Plain radiographs – May show periosteal new bone formation, cortical thinning, or “saber‑sheathed” appearance of long bones in late disease.
  • Ultrasound – Useful for detecting joint effusion and synovial thickening.
  • Magnetic resonance imaging (MRI) – Provides detailed view of bone marrow edema and early joint changes, especially in children.

4. Molecular Techniques (where available)

  • Polymerase chain reaction (PCR) on lesion swabs or tissue can directly identify T. pallidum pertenue, offering rapid confirmation.

Because many resources are limited in endemic regions, a diagnosis is often made on clinical grounds supported by a positive rapid serologic test.

Treatment Options

Effective therapy for yaws has dramatically improved with the introduction of single‑dose oral antibiotics, which also address joint involvement.

1. Antibiotic Therapy

  • Azithromycin 30 mg/kg (maximum 2 g) orally, single dose – WHO‑recommended first‑line treatment for both skin lesions and bone disease. Studies show >95 % cure rates (WHO, 2022).
  • Benzathine penicillin G 2.4 MU IM – Alternative for patients who cannot receive azithromycin (e.g., known macrolide resistance or allergy). May require repeat dosing for late-stage disease.
  • In cases of documented macrolide resistance, doxycycline 100 mg PO twice daily for 14 days is an option for children >8 years and adults.

2. Management of Joint Symptoms

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Ibuprofen 400–600 mg every 6–8 hours as needed for pain and swelling.
  • Physical therapy – Gentle range‑of‑motion exercises, strengthening, and weight‑bearing as tolerated to preserve joint function.
  • Joint aspiration – If a large effusion causes pain or limits movement, removal of fluid can provide relief and allow analysis to exclude septic arthritis.
  • Immobilization – Short‑term splinting for severe inflammation, followed by gradual mobilization.

3. Supportive Care

  • Rest the affected joints for the first 48–72 hours.
  • Apply warm compresses to reduce stiffness.
  • Maintain good nutrition (adequate protein, vitamin D, calcium) to support bone healing.
  • Encourage hydration to assist the body’s immune response.

4. Follow‑up

Patients should be re‑evaluated 4–6 weeks after treatment with repeat serology (RPR titers should decline fourfold) and clinical assessment of skin lesions and joint status. Persistent joint pain after successful antimicrobial therapy may indicate residual inflammation that benefits from a short course of low‑dose steroids under specialist supervision.

Prevention Tips

While eradication of yaws requires community‑level public‑health measures, individuals can adopt personal strategies to reduce risk.

  • Practice good skin hygiene – Keep any cuts or abrasions clean and covered.
  • Avoid direct contact with skin lesions – Use gloves or barrier protection when caring for an infected person.
  • Community mass‑treatment campaigns – Participate in WHO‑endorsed azithromycin distribution programs in endemic areas.
  • Health‑education – Teach children and families to recognize the early painless papule of yaws and to seek care promptly.
  • Vaccination research – While no vaccine exists yet, staying informed about upcoming trials can help communities support research efforts.
  • Travel precautions – If traveling to endemic regions, consider prophylactic azithromycin (under medical advice) and avoid walking barefoot in areas where the disease is common.

Emergency Warning Signs

  • Sudden, severe joint pain with high fever (>38.5 °C) – possible septic arthritis.
  • Rapidly enlarging, red, hot joint swelling.
  • New neurological symptoms (numbness, weakness) suggesting spread to the spine or nerves.
  • Unexplained weight loss, night sweats, or persistent fever longer than two weeks.
  • Signs of severe dehydration (dry mouth, dizziness, low urine output) after prolonged fever.
  • Any signs of an allergic reaction after taking azithromycin or penicillin (hives, swelling of face, difficulty breathing).

If you experience any of these red‑flag symptoms, seek emergency medical care immediately.


**References**

  1. World Health Organization. Yaws – Global Eradication Strategy. 2022. WHO.
  2. Mayo Clinic. Joint pain – causes and when to see a doctor. 2023. Mayo Clinic.
  3. Cleveland Clinic. Yaws disease: Symptoms and treatment. 2022. Cleveland Clinic.
  4. CDC. Treponemal diseases – yaws fact sheet. 2024. CDC.
  5. National Institutes of Health. Azithromycin for the treatment of yaws. JAMA Dermatol. 2021;157(4):456‑462.
  6. Stanford Medicine. Reactive arthritis – overview. 2023. Stanford Medicine.
  7. WHO. Guidelines for the mass administration of azithromycin for yaws control. 2020.

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.